For research use only. Not for therapeutic Use.
FASN-IN-5 (example 11), a FASN inhibitor, can be used for the research of TH17- or CSF1 -mediated disease or disorder such as cancer, immunological disorders, and obesity[1].
Catalog Number | I043853 |
CAS Number | 1309805-49-9 |
Synonyms | [(3S)-3-[[2-[4-(1-benzofuran-5-yl)phenyl]imidazo[4,5-c]pyridin-1-yl]methyl]pyrrolidin-1-yl]-cyclopropylmethanone |
Molecular Formula | C29H26N4O2 |
Purity | ≥95% |
InChI | InChI=1S/C29H26N4O2/c34-29(22-5-6-22)32-13-10-19(17-32)18-33-26-9-12-30-16-25(26)31-28(33)21-3-1-20(2-4-21)23-7-8-27-24(15-23)11-14-35-27/h1-4,7-9,11-12,14-16,19,22H,5-6,10,13,17-18H2/t19-/m1/s1 |
InChIKey | MXQGGBTXHJSPPG-LJQANCHMSA-N |
SMILES | C1CC1C(=O)N2CCC(C2)CN3C4=C(C=NC=C4)N=C3C5=CC=C(C=C5)C6=CC7=C(C=C6)OC=C7 |
Reference | [1]. David S. MILLAN, et al. Methods of using fasn inhibitors. WO2017189613A1. |